Biomarkers and Diabetes

Biomarkers have an imperative impact in leading clinical trials and treating patients. Advances in molecular diagnostics help restorative experts make proficient, scientifically valid decisions. All the more efficient discovery and utilization of biomarkers in the development of anti-diabetes drugs will rely on accelerating or understanding of the pathogenesis of diabetes and explicitly its macrovascular complications. Procedural enhancements from different fields, particularly disease, are starting to demonstrate the route towards better models of diabetes pathogenesis and molecular biomarker discovery.


  • Track 1-1 Serum biomarkers for diabetes
  • Track 2-2 Carbonyl stress
  • Track 3-3 Pulse wave analysis
  • Track 4-4 Auto fluorescence
  • Track 5-5 Biomarkers of vascular function in diabetes
  • Track 6-6 Salivary biomarkers for diabetes
  • Track 7-7 Novel biomarkers for diabetes
  • Track 8-8 Glycated haemoglobin biomarkers

Related Conference of Diabetes & Endocrinology